1
Diet and Psychosis: A Scoping Review - FullText - Neuropsychobiology 2020, Vol. 79, No. 1 - Karger Publishers
Introduction: Schizophrenia spectrum disorders (SSD) represent a cluster of severe mental illnesses. Diet has been identified as a modifiable risk factor and opportunity for intervention... [Read More]
1
Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone
Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone [Read More]
1
Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskinesia Assessment Workshop - PubMed
For both research and clinical practice, the AIMS is a valid measure for assessing TD and the effects of treatment, but alternative analyses of AIMS data (eg, effect size, minimal clinically important... [Read More]
1
Overcoming barriers to effective management of tardive dyskinesia
Tardive dyskinesia (TD) is a heterogeneous syndrome of involuntary hyperkinetic movements that is often persistent and occurs belatedly during treatment with antipsychotics. Recent approval of two dop... [Read More]
1
Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome | Molecular Psychiatry
Methamphetamine (Meth) abuse has reached epidemic proportions in many countries and can induce psychotic episodes mimicking the clinical profile of schizophrenia.  [Read More]
1
1
1
Is schizophrenia a neurodegenerative disorder? - PubMed
Schizophrenia is a biological and behavioural disorder, which manifests itself in neurocognitive dysfunction. The question of whether this key characteristic of the disorder is related to schizophreni... [Read More]
1
Animal models of schizophrenia - PubMed
Developing reliable, predictive animal models for complex psychiatric disorders, such as schizophrenia, is essential to increase our understanding of the neurobiological basis of the disorder and for ... [Read More]
1
Researchers discover second type of schizophrenia
Penn Medicine researchers are the first to discover two distinct neuroanatomical subtypes of schizophrenia after analyzing the brain scans of over 300 patients. The first type showed lower widespr... [Read More]
1
Postdoctoral Researcher - The Therapeutic Interventions for Psychosis Laboratory | Department of Psychology
Beginning immediately, all qualified candidates are invited to submit the following application materials to m.best@utoronto.ca:  1.     Curriculum vitae.  2. &nbs... [Read More]
1
Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis
Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis .entryAuthor" data-author-container-selector=".NLM_contrib-gro... [Read More]
1
Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia | SpringerLink
The objective of this article is to highlight the potential role of the galantamine-memantine combination as a novel antioxidant treatment for schizophrenia. [Read More]
1
Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics - PubMed
There is accumulating evidence of altered antioxidant enzyme activities and increased levels of lipid peroxidation in schizophrenia. Free radical-mediated abnormalities may contribute to specific aspe... [Read More]
1